Fourth Quarter 2020 Revenue Expected to More than Double Compared With Fourth Quarter 2019
Quarterly cash utilization is the lowest since IPO in 2017
CAMBRIDGE, Mass. (January 11, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced preliminary financial and operational results for the fourth quarter and fiscal year ended December 31, 2020. In particular, Myomo expects revenue for the three months ended December 31, 2020 to more than double compared with the fourth quarter ended December 31, 2019, and also expects quarterly cash utilization to be the lowest since it became a publicly traded company in June 2017. Read more.